Suppression of nicotinamide phosphoribosyltransferase expression by miR-154 reduces the viability of breast cancer cells and increases their susceptibility to doxorubicin

Overexpression of miR-182 inhibits ossification of ligamentum flavum cells by targeting NAMPT

(2018) Qiang Zhang et al.   EXPERIMENTAL CELL RESEARCH

Down-regulation of NAMPT expression by mir-206 reduces cell survival of breast cancer cells

(2018) Zahra Hesari et al.   GENE

Breast cancer diagnosis: Imaging techniques and biochemical markers

(2018) Seyed Hamed Jafari et al.   JOURNAL OF CELLULAR PHYSIOLOGY

miRNA-based strategy for modulation of influenza A virus infection

(2018) Mohsen Keshavarz et al.   Epigenomics

microRNA-300/NAMPT regulates inflammatory responses through activation of AMPK/mTOR signaling pathway in neonatal sepsis

(2018) Yexuzi Li et al.   BIOMEDICINE & PHARMACOTHERAPY

Potential Novel Therapy Targets in Neuroendocrine Carcinomas of the Breast

(2018) Semir Vranic et al.   Clinical Breast Cancer

Micro-RNAs as critical regulators of matrix metalloproteinases in cancer

(2018) Somaye Noruzi et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Inhibition of Nicotinamide Phosphoribosyltransferase Induces Apoptosis in Estrogen Receptor-Positive MCF-7 Breast Cancer Cells

(2017) Mohammad Alaee et al.   Journal of Breast Cancer

Extracellular NAMPT/Visfatin induces proliferation through ERK1/2 and AKT and inhibits apoptosis in breast cancer cells

(2017) Zafar Gholinejad et al.   PEPTIDES

MicroRNA-154 inhibits the growth and metastasis of gastric cancer cells by directly targeting MTDH

(2017) Wenhui Qiao et al.   Oncology Letters

Extracellular nicotinamide phosphoribosyltransferase, a new cancermetabokine

(2016) Ambra A Grolla et al.   BRITISH JOURNAL OF PHARMACOLOGY

Regulation of the Nampt-mediated NAD salvage pathway and its therapeutic implications in pancreatic cancer

(2016) Huai-Qiang Ju et al.   CANCER LETTERS

Downregulation of miR-154 in human glioma and its clinicopathological and prognostic significance

(2016) Lingling Wang et al.   JOURNAL OF INTERNATIONAL MEDICAL RESEARCH

MicroRNAs in breast cancer: oncogene and tumor suppressors with clinical potential

(2015) Wei Wang et al.   Journal of Zhejiang University-SCIENCE B

NAMPT suppresses glucose deprivation-induced oxidative stress by increasing NADPH levels in breast cancer

(2015) S M Hong et al.   ONCOGENE

miR-154 targeting ZEB2 in hepatocellular carcinoma functions as a potential tumor suppressor

(2015) Xiaoli Pang et al.   ONCOLOGY REPORTS

miR-154 suppresses non-small cell lung cancer growth in vitro and in vivo

(2015) XINGYU LIN et al.   ONCOLOGY REPORTS

MicroRNA-154 functions as a tumor suppressor in osteosarcoma by targeting Wnt5a

(2015) HUI ZHOU et al.   ONCOLOGY REPORTS

Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) as a therapeutic strategy in cancer

(2015) Deepak Sampath et al.   PHARMACOLOGY & THERAPEUTICS

Nicotinamide phosphorybosiltransferase overexpression in thyroid malignancies and its correlation with tumor stage and with survivin/survivin DEx3 expression

(2015) Nadia Sawicka-Gutaj et al.   TUMOR BIOLOGY

Decreased miR-154 expression and its clinical significance in human colorectal cancer

(2015) Yang Kai et al.   World Journal of Surgical Oncology

MiR-133a Is Functionally Involved in Doxorubicin-Resistance in Breast Cancer Cells MCF-7 via Its Regulation of the Expression of Uncoupling Protein 2

(2015) Yuan Yuan et al.   PLoS One

Dysregulated microRNA expression in adenocarcinoma of the uterine cervix: Clinical impact of miR-363-3p

(2014) Hyun Park et al.   GYNECOLOGIC ONCOLOGY

Expression of Nicotinamide Phosphoribosyltransferase-Influenced Genes Predicts Recurrence-Free Survival in Lung and Breast Cancers

(2014) Tong Zhou et al.   Scientific Reports

Elevated microRNA-34a in obesity reduces NAD+levels and SIRT1 activity by directly targeting NAMPT

(2013) Sung-E Choi et al.   AGING CELL

Targeting of NAD Metabolism in Pancreatic Cancer Cells: Potential Novel Therapy for Pancreatic Tumors

(2013) C. C. S. Chini et al.   CLINICAL CANCER RESEARCH

miR-154 suppresses colorectal cancer cell growth and motility by targeting TLR2

(2013) Chaoguang Xin et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Nicotinamide Phosphoribosyl Transferase (Nampt) Is a Target of MicroRNA-26b in Colorectal Cancer Cells

(2013) Chenpeng Zhang et al.   PLoS One

Down-regulation of NAMPT expression by miR-182 is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation

(2012) Xin-Yu Chen et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

MicroRNA Profiles in Familial and Sporadic Medullary Thyroid Carcinoma: Preliminary Relationships with RET Status and Outcome

(2012) Caterina Mian et al.   THYROID

High Visfatin Expression in Breast Cancer Tissue Is Associated with Poor Survival

(2011) Y.-C. Lee et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

The c-MYC oncoprotein, the NAMPT enzyme, the SIRT1-inhibitor DBC1, and the SIRT1 deacetylase form a positive feedback loop

(2011) A. Menssen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Human tumor microRNA signatures derived from large-scale oligonucleotide microarray datasets

(2010) Wenzhang Wang et al.   INTERNATIONAL JOURNAL OF CANCER

Resistance May Not Be Futile: microRNA Biomarkers for Chemoresistance and Potential Therapeutics

(2010) K. E. Allen et al.   MOLECULAR CANCER THERAPEUTICS

Visfatin stimulates proliferation of MCF-7 human breast cancer cells

(2010) Jae Geun Kim et al.   MOLECULES AND CELLS